Abstract
In March 2020, a 49-year-old man was admitted through our emergency department due to a 1-week history of fever (39–40°C) and cough. His medical history included arterial hypertension and a testicular seminoma in 2011 treated with surgery and platinum-based chemotherapy. Laboratory tests revealed increased C-reactive protein, mild lymphopenia, and thrombocytopenia. ChestCT showedmultifocal ground-glass opacities and nasopharyngeal swab was positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to a diagnosis of coronavirus disease 2019 (COVID-19). The patient was hospitalized and treatment with hydroxychloroquine, lopinavir/ritonavir, and ceftriaxone was started.
Lingua originale | English |
---|---|
pagine (da-a) | 978-983 |
Numero di pagine | 6 |
Rivista | Neurology |
Volume | 95 |
DOI | |
Stato di pubblicazione | Pubblicato - 2020 |
Keywords
- Antiviral Agents
- Bradycardia
- COVID-19
- Deglutition Disorders
- Diagnosis, Differential
- Dysphonia
- Facial Nerve Diseases
- Gastroparesis
- Guillain-Barre Syndrome
- Humans
- Hypertension
- Hypoglossal Nerve Diseases
- Male
- Middle Aged
- Muscle Weakness
- Neck Muscles
- Polyneuropathies
- Respiration, Artificial
- Respiratory Insufficiency
- Tachycardia
- Upper Extremity